Results 241 to 250 of about 3,877,321 (353)
Abstract We analyze how public risk disclosure, specifically Solvency II, impacts life insurers' risk‐taking behavior. Using data from 58 German life insurers from 2016 to 2023, we find that publicly reported solvency ratios can affect premium growth and surrender rates.
Moritz Hanika
wiley +1 more source
Conditional Survival Rate of Patients Undergoing Gastrectomy with D2 Lymph Node Dissection After Neoadjuvant Chemotherapy: A Retrospective Study. [PDF]
Yang X, Meng F, Cai F, Deng J.
europepmc +1 more source
Virtuous innovation or obfuscation? Product innovation in the variable annuities market
Abstract Variable Annuities, which comprise a substantial proportion of the retirement products sold by insurance companies, have become increasingly complex over the past decades. We investigate the drivers of the product trends. We distinguish “virtuous” innovations that expand upon the existing set of consumption paths in retirement from ...
Xiaochen Jing +2 more
wiley +1 more source
Using best-worst scaling experiment to understand factors influencing self-medication practices with antimicrobial drugs: A survey of students studying health programs at a tertiary institution in Ghana. [PDF]
Nyarko E +3 more
europepmc +1 more source
Smooth backfitting for additive hazard rates
Abstract Smooth backfitting was first introduced in an additive regression setting via a direct projection alternative to the classic backfitting method by Buja, Hastie, and Tibshirani. This paper translates the original smooth backfitting concept to a survival model considering an additively structured hazard.
Stephan M. Bischofberger +3 more
wiley +1 more source
Correction: A new asymmetric extended family: Properties and estimation methods with actuarial applications. [PDF]
Aljohani HM +5 more
europepmc +1 more source
Abstract Hepatocellular carcinoma (HCC) is the sixth most common malignancy and the third leading cause of cancer‐related death worldwide. Contemporary advances in systemic and locoregional therapies have led to changes in peer‐reviewed guidelines regarding systemic therapy as well as the possibility of downstaging disease that may enable some patients
Dimitrios Moris +12 more
wiley +1 more source
Amyloid-negative neuropsychological norms: Added value in the era of biomarkers and disease-modifying therapies. [PDF]
Rubio-Guerra S +29 more
europepmc +1 more source

